Come up with a name for your new list and we'll add to it:
Neomics raised a round of funding on October 03, 2008. Investors include
Novartis Venture Funds.
Neomics is a drug discovery and diagnostics company with a unique cancer target and biomarker discovery platform. In particular, Neomics is focused on novel targets and biomarkers relevant to aminoacy…